High Tower Advisors, LLC Esperion Therapeutics, Inc. Call Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $6,440 - $10,920	4,000 Added 30.77%	17,000 $28,000
Q2 2024 Aug 13, 2024	BUY	$1.84 - $3.24 $5,152 - $9,072	2,800 Added 27.45%	13,000 $28,000
Q1 2024 May 06, 2024	BUY	$2.02 - $3.02 $20,604 - $30,804	10,200 New	10,200 $27,000
Q2 2020 Aug 10, 2020	SELL	$30.04 - $51.31 $72,096 - $123,144	-2,400 Reduced 70.59%	1,000 $22,000
Q1 2020 May 21, 2020	BUY	$27.44 - $73.84 $16,464 - $44,304	600 Added 21.43%	3,400 $30,000
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $21,240 - $35,892	600 Added 27.27%	2,800 $83,000
Q3 2019 Nov 12, 2019	BUY	$34.47 - $47.53 $75,834 - $104,566	2,200 New	2,200 $25,000

208

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.